Bill Gates invests in Alzheimer’s research
Gates will invest $50 million in the Dementia Discovery Fund. This will be followed by another $50 million investment in startups working on Alzheimer's research.
Quest Diagnostics’ iPad app automates dementia screening
A pilot began with just a handful of doctors, but was broadened beyond primary care when it was found to be easy to use and capable of producing valuable information—especially to “downstream” physicians.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The first drugs able to prevent or delay Alzheimer’s could come from research with younger adults with a rare gene mutation
Success in finding drugs to treat Alzheimer's disease could have more promise when experimenting with those too young to show symptoms.
Alzheimer’s patients are twice as likely to have previously suffered from depression
A new study published in the journal Neurology suggests that before memory loss kicks in for Alzheimer’s patients, they could have experienced things like depression, anxiety, sleep problems or appetite changes. “I wouldn’t worry at this point if you’re feeling anxious, depressed or tired that you have underlying Alzheimer’s, because in most cases it has […]